Pacer Advisors Inc. Has $8.17 Million Stock Position in Colgate-Palmolive (NYSE:CL)

Pacer Advisors Inc. lessened its position in Colgate-Palmolive (NYSE:CL - Free Report) by 19.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 89,850 shares of the company's stock after selling 21,422 shares during the period. Pacer Advisors Inc.'s holdings in Colgate-Palmolive were worth $8,168,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Peak Financial Advisors LLC bought a new position in Colgate-Palmolive during the 4th quarter valued at $1,315,000. Gordian Advisors LLC acquired a new position in Colgate-Palmolive during the third quarter worth about $602,000. Carrera Capital Advisors raised its position in Colgate-Palmolive by 23.1% in the third quarter. Carrera Capital Advisors now owns 39,170 shares of the company's stock worth $4,066,000 after acquiring an additional 7,353 shares in the last quarter. Fiduciary Alliance LLC bought a new position in shares of Colgate-Palmolive during the 4th quarter valued at about $4,066,000. Finally, Vontobel Holding Ltd. grew its stake in shares of Colgate-Palmolive by 224.6% in the 3rd quarter. Vontobel Holding Ltd. now owns 795,938 shares of the company's stock worth $82,626,000 after purchasing an additional 550,750 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors.

Insider Activity

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the transaction, the chief financial officer now directly owns 36,726 shares in the company, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.34% of the stock is owned by corporate insiders.

Colgate-Palmolive Price Performance

CL traded up $1.39 during midday trading on Thursday, reaching $90.96. 5,361,124 shares of the company's stock were exchanged, compared to its average volume of 5,068,158. Colgate-Palmolive has a one year low of $82.68 and a one year high of $109.30. The firm has a market capitalization of $74.31 billion, a price-to-earnings ratio of 26.06, a price-to-earnings-growth ratio of 3.59 and a beta of 0.44. The business has a 50-day simple moving average of $91.58 and a two-hundred day simple moving average of $97.29. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.20%. Colgate-Palmolive's payout ratio is presently 57.31%.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on CL. TD Cowen cut their target price on Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating on the stock in a research report on Wednesday, January 8th. StockNews.com lowered Colgate-Palmolive from a "buy" rating to a "hold" rating in a report on Thursday, January 9th. Royal Bank of Canada reiterated a "sector perform" rating and set a $101.00 price target on shares of Colgate-Palmolive in a research note on Wednesday. Wells Fargo & Company cut their price objective on Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating on the stock in a research note on Tuesday, January 7th. Finally, Piper Sandler decreased their target price on Colgate-Palmolive from $121.00 to $112.00 and set an "overweight" rating for the company in a research report on Monday, January 6th. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $102.00.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.